British HIV Association (BHIVA) guidelines for the treatment of HIV‐infected adults with antiretroviral therapy (2006)
Authors:
- B GazzardBGB Gazzard
- on behalf of the BHIVA Writing CommitteeOCon behalf of the BHIVA Writing Committee
- 13 November 2006
- journal article
- practice guideline
- Published by Wiley in HIV Medicine
- Vol. 7 (8) , 487-503
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Changing the Paradigm for HIV Testing — The End of ExceptionalismNew England Journal of Medicine, 2006
- Effects of drug resistance on viral load in patients failing antiretroviral therapyJournal of Medical Virology, 2006
- Minor changes in calculated creatinine clearance and anion‐gap are associated with tenofovir disoproxil fumarate‐containing highly active antiretroviral therapyHIV Medicine, 2006
- Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational studyBMJ, 2005
- Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppressionScandinavian Journal of Infectious Diseases, 2005
- Multidisciplinary HIV Adherence Intervention: A Randomized StudyAIDS Patient Care and STDs, 2004
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjectsAIDS, 2003
- Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 TrialThe Journal of Infectious Diseases, 2003
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999